No abstract available
Publication types
-
Case Reports
-
Comment
-
Letter
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols
-
Bone Marrow Transplantation
-
Disease Progression
-
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
-
Hemolytic-Uremic Syndrome / chemically induced
-
Hemolytic-Uremic Syndrome / etiology*
-
Humans
-
Hydroxyurea / therapeutic use
-
Interferon Type I / adverse effects
-
Interferon-alpha / adverse effects*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Male
-
Middle Aged
-
Recombinant Proteins
-
Transplantation, Autologous
Substances
-
Interferon Type I
-
Interferon-alpha
-
Recombinant Proteins
-
Granulocyte-Macrophage Colony-Stimulating Factor
-
Hydroxyurea